SCHEMBL8350912

SCHEMBL8350912

O=C(NCc1cccc2ccccc12)c1cccc(-c2ccnc(Nc3ccccc3)c2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK1D P48730 1/20 0.53
▸ MAPK8 P45983 3/20 0.50
▸ MAPK10 P53779 3/20 0.50
▸ CYP2C9 P11712 2/20 0.49
▸ CHRNB2 P17787 1/20 0.49
▸ CHRNA4 P43681 1/20 0.49
▸ MEN1 O00255 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ EPHX2 P34913 1/20 0.46
▸ NR1H4 Q96RI1 1/20 0.46
▸ ROCK1 Q13464 2/20 0.45
▸ JAK2 O60674 1/20 0.45
▸ MAP4K4 O95819 1/20 0.45
▸ CHEK2 O96017 1/20 0.45
▸ PRKCG P05129 1/20 0.45
▸ CDK1 P06493 1/20 0.45
▸ FES P07332 1/20 0.45
▸ RET P07949 1/20 0.45
▸ ROS1 P08922 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8352104 0.87 CFD (0.59) MAPK8MAPK10EPHX2NR1H4ROCK1
SCHEMBL8352106 0.85 SMN1; SMN2 (0.52) MAPK8MAPK10MAPTROCK1JAK2
SCHEMBL8349712 0.85 ABL1 (0.53) CSNK1DMAPK8MAPK10CYP2C9CHRNB2
SCHEMBL1928101 0.83 CHRNB2 (0.64) CSNK1DCYP2C9CHRNB2CHRNA4MEN1
SCHEMBL8349000 0.82 MAPK10 (0.48) MAPK8MAPK10EPHX2NR1H4ROCK1
SCHEMBL8351088 0.80 ALDH1A1 (0.62) MAPK8MAPK10MEN1MAPTKMT2A
SCHEMBL8351021 0.80 HPGD (0.56) MAPK8MAPK10MEN1MAPTKMT2A
SCHEMBL6798961 0.78 CYP2C9 (0.54) CSNK1DCYP2C9CHRNB2CHRNA4MEN1
SCHEMBL5213910 0.78 CA2 (0.54) CSNK1DCYP2C9CHRNB2CHRNA4MEN1
SCHEMBL8351466 0.77 ROCK2 (0.64) MAPK8MAPK10CYP2C9EPHX2NR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312227-B2 Compositions useful as inhibitors of JAK and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-12-25 — — US disclosed
US-7312227-B2 Compositions useful as inhibitors of JAK and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-12-25 — — US disclosed
WO-2004041789-A1 COMPOSITIONS USEFUL AS INHIBITORS OF JAK AND OTHER PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2004-05-21 — — WO disclosed
Send feedback